Navigation Links
Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
Date:2/6/2008

not indicative of our normal operating costs.

We exclude certain acquisition-related costs, including charges for the sale of inventories revalued at the date of acquisition and professional fees related to the merger with Fisher. We exclude these costs because we do not believe they are indicative of our normal operating costs.

We exclude the expense and tax effects associated with the amortization of acquisition-related intangible assets because a significant portion of the purchase price for acquisitions may be allocated to intangible assets that have lives of 5 to 20 years. Our adjusted EPS estimate for 2008 excludes approximately $.89 of expense for the amortization of acquisition-related intangible assets for acquisitions completed through the fourth quarter of 2007. Exclusion of the amortization expense allows comparisons of operating results that are consistent over time for both our newly acquired and long- held businesses and with both acquisitive and non-acquisitive peer companies.

We also exclude certain gains/losses and related tax effects, benefits from tax credit carryforwards and the impact of significant tax audits or events (such as the one-time effect on deferred tax balances of enacted changes in tax rates), which are either isolated or cannot be expected to occur again with any regularity or predictability and that we believe are not indicative of our normal operating gains and losses. For example, we exclude gains/losses from items such as the sale of a business or real estate, the early retirement of debt and debt facilities and discontinued operations.

Thermo Fisher's management uses these non-GAAP measures, in addition to GAAP financial measures, as the basis for measuring the company's core operating performance and comparing such performance to that of prior periods and to the performance of our competitors. Such measures are also used by management in their financial and operating decision-making and for compen
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related biology technology :

1. Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
2. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
3. Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Thermo Fisher Scientific to Present at the 26th Annual JPMorgan Healthcare Conference
5. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
6. Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing
7. MIT: Thermoelectric materials are 1 key to energy savings
8. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
9. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
10. Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers
11. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellT...willpresentatthe21stAnnualPiperJaffrayHealthCareCo...ttheNewYorkPalaceHotel. ,, CTIwillpresentonTues...oor).AliveaudiowebcastofCTI,spresentationwillbeava...availableforreplayafterwards. , ,PiperJaffrayHeal...
(Date:11/23/2009)..., INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-First...nnouncedthatNASDAQhasestablishedNovember27,2009ast...ostockholdersresultingfromthesecuritizationtransac...donDecember15,2009toallstockholdersofrecordonthere...pershareamountofthedividendat$1.67pershareofcommon...
(Date:11/23/2009)..., BURNABY,BC,Nov.23/PRNewswire/-InimexPharmac...elJ.Abrams,Ph.DasitsPresidentandCEO. ,, Abramsb...xperiencetoInimex.Heisaco-inventorofthenuclearmedi...6atJohnsonMatthey,plcwherehewasManager,BiomedicalR...fAnorMEDinLangley,BCandwasPresidentandCEOfrom1996t...
(Date:11/20/2009)... Spain and Latin American countries have an opport...sectors. Researchers from the University of Valenc...ion, have studied the productive fabric of the Spa...hat Spain,s food and plant sectors have more clout...technology as applied to food and plants has been ...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Inimex Announces Appointment of New CEO 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2
...ANTON, Calif., Nov. 19 Thoratec,Corporation (Nasd...ardiovascular disease, today announced the appoint...ts board of directors, effective January 1,2008. H...irectors. Collis, who will join the board,s compe...esident of AmerisourceBergen Corporation, and pres...
...ALTO, Calif., Nov 19 CV Therapeutics,Inc. (Nasdaq...rug,Administration (FDA) has notified the Company ...and new drug application (NDA) for Ranexa(R),(rano...ccepted for filing.,The Prescription Drug User Fee...July 27, 2008. The sNDA seeks an expansion to the...
...nes from Wyeth and GlaxoSmithKline Will Also Be Vy...ccal Vaccine Market, According to a New ..., Mass., Nov. 19 Decision Resources, one of the,w...rmaceutical and,healthcare issues, finds that the ...treatment of community-acquired pneumonia are intr...
Other Biology Technology:Thoratec Announces Appointment of Steven H. Collis to Board of Directors 2Thoratec Announces Appointment of Steven H. Collis to Board of Directors 3FDA Accepts Ranexa(R) sNDA and NDA for Filing 2FDA Accepts Ranexa(R) sNDA and NDA for Filing 3Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline 2
(Date:11/23/2009)...sty business, posing dangers to human health and t... launching a new project with funding from the U.S...ts the fat and grease that contribute to millions ...ers new tools to further reduce the risk of sewage..." sewer systems, as opposed to "combined" systems ...
(Date:11/22/2009)...scientists have inventoried an astonishing abundan... that have never known sunlight - creatures that s...n to 5,000 meters (~3 miles) below the ocean waves...other vanguard technologies, animals known to thri..., a diverse collection of species ranging from cra...
(Date:11/21/2009)...mber 20,2009 / b3c newswire / - KINAXO Biotechno...ng round, gaining two new investors in the company...XO reports that Jrgen Schumacher has been elected ... KINAXO shareholders Axel Ullrich, Hellmut Kirchn...tional investors Mountain Partners, BioM, High-Tec...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Moderate Drinking Guards the Heart 61733 1Moderate Drinking Guards the Heart 61733 2Moderate Drinking Guards the Heart 61733 3Immunology expert at Childrens Hospital receives APS prize for patient oriented research 61730 1Immunology expert at Childrens Hospital receives APS prize for patient oriented research 61730 2Technique finds gene regulatory sites without knowledge of regulators 10814 1Technique finds gene regulatory sites without knowledge of regulators 10814 2
...al Fingerprint Reader to be the Latest Addition to...Suite, ATLANTA, Aug. 14 M2SYS Technology, a biom...nounced today its partnership,with SecuGen Corpora...ader,the Hamster Plus. The Hamster Plus fingerpri...hat automatically checks for the presence of a fin...
... Deployment Reaches 275,000 Enrollment Milestone, ...ice,solutions showcase, PerSay, the leader in voic...rd technology powers Bell,s Voice,Identification S...in,Canada, has made a spoken pass phrase the unive...ervice segments (wireline, wireless, high-speed,In...
...equence and assembly of the six billion base pairs...f individualized genomics , Researchers at the J....rators at The Hospital for Sick Children in Toront...), have published a genome sequence of an individu...omes that were inherited from each parent. , Tw...
Other Biology News:M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology 2Voice Biometrics Gains Traction as Most Accurate and Convenient Technology to Secure Customer Privacy 2First individual genome sequence published 2First individual genome sequence published 3First individual genome sequence published 4
...Purity is >95%\nNEN Radiolabeled Ligands\n\nRecept...ontinual availability of new radiolabeled ligands ...Elmer offers a wide range of products and services...ng over 400 state-of-the-art radioligands. If you ...
iTaq DNA Polymerase, 5,000 U from Bio-Rad
iTaq DNA Polymerase, 250 U from Bio-Rad
Rabbit Anti-Human RHEB (IN) Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: